Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by 18F-FDG-PET is associated with the KRAS mutation status and prognosis

The effect of preoperative chemotherapy treatment in surgically treated intrahepatic cholangiocarcinoma patients-A multi-institutional analysis

(2017) Stefan Buettner et al.   JOURNAL OF SURGICAL ONCOLOGY

Neutrophil-to-lymphocyte ratio predicts prognosis after neoadjuvant chemotherapy and resection of intrahepatic cholangiocarcinoma

(2017) Kiyohiko Omichi et al.   SURGERY

Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients

(2015) Andrea Ruzzenente et al.   ANNALS OF SURGICAL ONCOLOGY

Clinical Validation of a Multiplex Kit for RAS Mutations in Colorectal Cancer: Results of the RASKET (RAS KEy Testing) Prospective, Multicenter Study

(2015) Takayuki Yoshino et al.   EBioMedicine

Genomic Profiling of Intrahepatic Cholangiocarcinoma: Refining Prognosis and Identifying Therapeutic Targets

(2014) Andrew X. Zhu et al.   ANNALS OF SURGICAL ONCOLOGY

Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer

(2014) Carlos Caicedo et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma

(2014) Yuichiro Kubo et al.   HUMAN PATHOLOGY

High Prognostic Value of 18F-FDG PET for Metastatic Gastroenteropancreatic Neuroendocrine Tumors: A Long-Term Evaluation

(2014) H. Bahri et al.   JOURNAL OF NUCLEAR MEDICINE

Cholangiocarcinoma

(2014) Nataliya Razumilava et al.   LANCET

Mutational landscape of intrahepatic cholangiocarcinoma

(2014) Shanshan Zou et al.   Nature Communications

Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma

(2014) Michael N. Mavros et al.   JAMA Surgery

Simultaneous identification of 36 mutations in KRAS codons 61and 146, BRAF, NRAS, and PIK3CAin a single reaction by multiplex assay kit

(2013) Hideaki Bando et al.   BMC CANCER

Multidisciplinary approaches to intrahepatic cholangiocarcinoma

(2013) Shishir K. Maithel et al.   CANCER

Prediction of the Postoperative Prognosis of Intrahepatic Cholangiocarcinoma (ICC): Importance of Preoperatively-Determined Anatomic Invasion Level and Number of Tumors

(2013) Shigeru Marubashi et al.   DIGESTIVE DISEASES AND SCIENCES

Prognostic significance of preoperative metabolic tumour volume and total lesion glycolysis measured by 18F-FDG PET/CT in squamous cell carcinoma of the oral cavity

(2013) In Sun Ryu et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

The frequency of KRAS and BRAF mutations in intrahepatic cholangiocarcinomas and their correlation with clinical outcome

(2013) Scott Robertson et al.   HUMAN PATHOLOGY

Prognostic Nomogram for Intrahepatic Cholangiocarcinoma After Partial Hepatectomy

(2013) Yizhou Wang et al.   JOURNAL OF CLINICAL ONCOLOGY

Relationship between 18F-Fluorodeoxyglucose Accumulation and KRAS/BRAF Mutations in Colorectal Cancer

(2012) K. Kawada et al.   CLINICAL CANCER RESEARCH

A prognostic scoring system based on clinical features of intrahepatic cholangiocarcinoma: the Fudan score

(2011) W. Jiang et al.   ANNALS OF ONCOLOGY

Proliferative activity in hepatocellular carcinoma is closely correlated with glucose metabolism but not angiogenesis

(2011) Koji Kitamura et al.   JOURNAL OF HEPATOLOGY

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

(2010) Stephen B. Edge et al.   ANNALS OF SURGICAL ONCOLOGY

Intrahepatic Cholangiocarcinoma

(2009) Itaru Endo et al.   ANNALS OF SURGERY

Oncogenic KRAS and BRAF Differentially Regulate Hypoxia-Inducible Factor-1  and -2  in Colon Cancer

(2009) H. Kikuchi et al.   CANCER RESEARCH

Descriptive epidemiology of cholangiocarcinoma in Italy

(2009) Domenico Alvaro et al.   DIGESTIVE AND LIVER DISEASE

18F-FDG Uptake in Lung, Breast, and Colon Cancers: Molecular Biology Correlates and Disease Characterization

(2009) H. Jadvar et al.   JOURNAL OF NUCLEAR MEDICINE

Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells

(2009) J. Yun et al.   SCIENCE

Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]-2-fluro-2-deoxy-d-glucose positron emission tomography

(2008) Bishnuhari Paudyal et al.   CANCER SCIENCE